Recent and other important news items

• Pharmerit publication on quality-of-live impact of alpha-blocker and anti-muscarinic combination treatment positively reviewed by NHS

  2013-05-01 - Pharmerit proudly announces that its publication “Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic co...Read more

  ---

• Pharmerit Participates in the 25th Annual Meeting & Expo of the Academy of Managed Care Pharmacy (AMCP)

  2013-04-29 - Pharmerit International staff participated as exhibitors at AMCP’s 25th Annual Meeting & Expo held April 3-5th at the San Diego Convention Ce...Read more

  ---

• Pharmerit sponsored MTA price won by Aukje van Gestel for article on expected value of individualized care.

  2012-12-04 - At the annual symposium of the Dutch Society for Technology Assessment in Healthcare (NVTAG), Aukje was awarded the MTA price for her article on the e...Read more

  ---

• Pharmerit manuscript about cost-effectiveness of paliperidone ER in Spain published in Journal of Medical Economics

  2012-11-09 - The results of Pharmerit’s cost-effectiveness research on paliperidone ER in Spain were published in the Journal of Medical Economics (September 27, 2...Read more

  ---

• Quality of Life Study in Hemophilia Published in Value in Health

  2012-10-10 - Pharmerit International is proud to congratulate Pharmerit Staff member Cailtyn Solem, PhD and her coauthors Ellis J. Neufeld, MD, PhD, Michael Recht,...Read more

  ---